4/A: Herbalife COO Amends SAR Exercise Price to $19.26
Insider Transaction Amendment
Herbalife's Chief Operating Officer, Troy Hicks, filed an amended Form 4 to correct the exercise price of 33,301 Stock Appreciation Rights to $19.26.
Summary
- Troy Hicks, Chief Operating Officer of Herbalife Ltd., filed an amended Form 4 (Form 4/A).
- The amendment was filed solely to correct the exercise price of 33,301 Stock Appreciation Rights (SARs).
- The corrected exercise price for the SARs is $19.26, which was previously reported as $10.51.
- These SARs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
- The SARs will vest in one-third increments on February 25, 2027, February 25, 2028, and February 25, 2029, contingent on continued service.
- The expiration date for these Stock Appreciation Rights is February 25, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, merely a correction of an administrative error in an executive compensation disclosure, with no direct impact on company operations or financial performance.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Form 4/A filings are routine for correcting administrative errors in insider transaction reports. This specific correction of an SAR exercise price is a technical detail related to executive compensation, common across industries where equity incentives are used.
Stakeholder Impact
- Shareholders: Provides accurate disclosure regarding executive equity compensation, ensuring transparency.
Key Dates
| Date | Description |
|---|---|
| 02/25/2026 | Date of earliest transaction (grant of Stock Appreciation Rights) |
| 02/27/2026 | Date original Form 4 was filed |
| 03/03/2026 | Date of signature for the amended Form 4 |
| 02/25/2027 | First vesting date for Stock Appreciation Rights |
| 02/25/2028 | Second vesting date for Stock Appreciation Rights |
| 02/25/2029 | Third vesting date for Stock Appreciation Rights |
| 02/25/2036 | Expiration date for Stock Appreciation Rights |
Recommendation
holdThis filing is an administrative correction of an executive's Stock Appreciation Rights exercise price. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should maintain their current position based on broader company fundamentals.
Keywords
Herbalife, HLF, Form 4/A, SEC filing, Stock Appreciation Rights, SARs, Troy Hicks, Chief Operating Officer, Executive Compensation, Insider Trading, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.